VPVasiliki Patsiou

Vasiliki Patsiou

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Vasiliki Patsiou has a total of 50 co-authors. Here are the top co-authors by number of shared publications:

  • George Giannakoulas

    Aristotle University of Thessaloniki

    4 shared publications
  • Athanasios Samaras

    Second Department of Cardiology, Ippokratio General Hospital, Aristotle University of Thessaloniki, 546 42 Thessaloniki, Greece

    3 shared publications
  • Amalia Baroutidou

    First Department of Cardiology, AHEPA University Hospital, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece

    2 shared publications
  • Antonios Ziakas

    Pulmonary Hypertension and Congenital Heart Disease Unit, AHEPA University General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece

    2 shared publications
  • Alexandra Arvanitaki

    Pulmonary Hypertension and Congenital Heart Disease Unit, AHEPA University General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece

    1 shared publication
  • Alexandra Bekiaridou

    First Department of Cardiology, AHEPA University Hospital, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece

    1 shared publication

Latest Publications

  • Overview of BioASQ 2026: The Fourteenth BioASQ Challenge on Large-Scale Biomedical Semantic Indexing and Question Answering

    by Anastasios Nentidis, Georgios Katsimpras, Anastasia Krithara, Martin Krallinger, Miguel Rodríguez-Ortega, Eduard Rodríguez-López, Natalia Loukachevitch, Igor Rozhkov, Elena Tutubalina, Dimitris Dimitriadis, et al.

  • Efficacy and Tolerability of Selexipag in Pediatric Patients with Pulmonary Arterial Hypertension: An Updated Systematic Review and Meta-analysis

    by Vasiliki Patsiou, Triantafyllia Grantza, Thomas Chrysochoidis-Trantas, Maria Kavga, Nikolaos Fragakis, Antonios Ziakas, Alexandra Arvanitaki, George Giannakoulas

    Evidence supporting selexipag in pediatric pulmonary arterial hypertension (PAH) is sparse, mainly from small, heterogeneous studies. This meta-analysis assessed its efficacy and tolerability in this population. A systematic search of PubMed, Embase, Web of Science, Cochrane Library, and Scopus was conducted until April 2025. Eligible studies included patients under 18 years diagnosed with PAH and treated with selexipag, reporting clinical outcomes. Two reviewers independently screened, extracted data, and evaluated study quality. Pooled analyses of efficacy and safety outcomes were performed, with subgroup comparisons for add-on therapy versus transition from parenteral prostacyclin analogs. Twelve studies involving 344 pediatric patients (90.6% diagnosed with PAH) were included. Selexipag significantly improved 6-minute walk distance (SMD: − 0.75; 95% CI: − 1.22 to − 0.29; P = 0.002), but did not affect pulmonary vascular resistance index, mean pulmonary artery pressure (mPAP), or NT-proBNP. Sensitivity analysis revealed reduced mPAP in PAH-only studies (SMD: − 0.30; P = 0.03). Adverse events occurred in 62.8%, predominantly mild. Functional improvement was greater in the add-on therapy group, which also experienced more adverse events. Selexipag improved functional capacity and mPAP in pediatric PAH and was generally well tolerated. Further prospective studies are needed to confirm long-term benefits.

  • Open Access

    Chat GPT Against Medical Students: A Comparative Analysis of Image-Based Medical Examination Results

    by Andreas Sarantopoulos, Zoe Dorothea Pana, Andreas Larentzakis, Sophia Kondylis, Anna Maina, Nikolaos Ziogas, Maria Marinakis, Vasiliki Patsiou, Dimitrios Ntourakis

    Background Artificial intelligence (AI), particularly large language models like ChatGPT, is increasingly shaping medical education. While these systems show promise for automated feedback and adaptive assessments, their performance in visually intensive, image-based disciplines remains insufficiently studied. Objective To compare the performance of ChatGPT-4.0 and undergraduate medical students on standardized, image-based multiple-choice questions in Anatomy, Pathology, and Pediatrics, evaluating domain-specific strengths and limitations of generative AI in visual reasoning. Standardized exams were administered to second-, third-, and fifth-year students, and the same questions were submitted to ChatGPT-4.0 using a two-step deterministic and stochastic protocol. Items with images that ChatGPT failed to recognize were excluded. Student responses were pooled after verifying normality, variance, and sample size equivalence, with subgroup analyses restricted to questions with a discrimination index ≥ 0.1. Paired t-tests or Wilcoxon signed-rank tests were used for comparisons. Results Of 90 questions, only 52 were eligible for analysis due to ChatGPT’s inability to interpret certain images. ChatGPT significantly underperformed in Anatomy (mean difference = − 0.387, p < 0.00001, d = 2.10), with similar results in the discrimination-based subgroup. In contrast, ChatGPT outperformed students in Pediatrics (mean difference = + 0.174, p = 0.00013, d = 0.81), with a greater effect in the validated subgroup. Pathology was excluded from comparison due to complete image recognition failure. Conclusion These findings demonstrate marked variability in ChatGPT’s visual reasoning across medical domains, underlining the need for multimodal integration and critical evaluation of AI applications to enhance AI effectiveness in medical education.

  • Open Access

    Epicardial Versus Endocardial Pacing in Paediatric Patients with Atrioventricular Block or Sinus Node Dysfunction: A Systematic Review and Meta-analysis

    by Vasiliki Patsiou, Anna-Bettina Haidich, Amalia Baroutidou, Andreas Giannopoulos, George Giannakoulas

    Pacing indications in children are clearly defined, but whether an epicardial (EPI) or an endocardial (ENDO) pacemaker performs better remains to be elucidated. This systematic review and meta-analysis aimed to directly compare the incidence of pacemaker (PM) lead-related complications, mortality, hemothorax and venous occlusion between EPI and ENDO in children with atrioventricular block (AVB) or sinus node dysfunction (SND). Literature search was conducted in MEDLINE (via PubMed), Scopus by ELSEVIER, Cochrane Central Register of Controlled Trials (CENTRAL), Web of Science, and OpenGrey databases until June 25, 2022. Random-effects meta-analyses were performed to assess the pacing method’s effect on lead failure, threshold rise, post-implantation infection and battery depletion and secondarily on all-cause mortality, hemothorax and venous occlusion. Several sensitivity analyses were also performed. Of 22 studies initially retrieved, 18 were deemed eligible for systematic review and 15 for meta-analysis. Of 1348 pediatric patients that underwent EPI or ENDO implantation, 542 (40.2%) had a diagnosis of congenital heart disease (CHD). EPI was significantly associated with higher possibility of PM-lead failure [pooled odds ratio (pOR) 3.00, 95% confidence interval (CI) 2.05–4.39; I2 = 0%]; while possibility for threshold rise, post-implantation infection and battery depletion did not differ between the PM types. Regarding the secondary outcome, the mortality rates between EPI and ENDO did not differ. In sensitivity analyses the results were consistent results between the two PM types. The findings suggest that EPI may be associated with increased PM-lead failure compared to ENDO while threshold rise, infection, battery depletion and mortality rates did not differ.


  • Open Access

    Sex-Related Differences in Clinical Outcomes in Patients with Atrial Fibrillation and Coronary Artery Disease: A Sub-Study of the MISOAC-AF Randomized Controlled Trial

    by Alexandra Bekiaridou, Athanasios Samaras, Anastasios Kartas, Andreas S. Papazoglou, Dimitrios V. Moysidis, Vasiliki Patsiou, Stefanos Zafeiropoulos, Antonios Ziakas, George Giannakoulas, Apostolos Tzikas

    Background: There is limited “real-world” data on the prognostic role of gender in comorbid atrial fibrillation (AF) and coronary artery disease (CAD). Methods: In this post-hoc analysis of the MISOAC-AF randomized trial (NCT: 02941978), consecutive patients with AF and CAD who were discharged from the cardiology ward between 2015 and 2018 were included. Multivariable Cox-regression analysis was performed for all-cause mortality and cardiovascular (CV) mortality. Competing-risk analysis was performed for the outcomes of stroke or systemic embolism, major bleeding, AF- or heart failure (HF)-related hospitalization, adjusted for the competing risk of all-cause death. Results: Of 1098 patients with AF, 461 patients with comorbid CAD were analyzed. Women were older and more likely to have a history of diabetes mellitus and valvular heart disease, while men were more likely to have a history of smoking or myocardial infarction. Over a median follow-up of 31 months, 143 (43.4%) men and 71 (53.7%) women died. Women were at a higher risk for all-cause mortality (adjusted hazard ration [aHR] 1.65; 95% confidence interval [CI] 1.14–2.38) and stroke or systemic embolism (aHR 3.52; 95% CI 1.46–8.49) compared to men. The risks of CV mortality, major bleeding, AF-related hospitalization, and HF-related hospitalization were similar between genders. Conclusions: In recently hospitalized patients with AF and comorbid CAD, the female gender was independently associated with increased all-cause mortality and thromboembolic events.


  • Prognostic implications of adherence to oral anticoagulants among patients with atrial fibrillation: Insights from MISOAC-AF trial

    by Vasiliki Patsiou, Athanasios Samaras, Anastasios Kartas, Dimitrios V. Moysidis, Andreas S. Papazoglou, Alexandra Bekiaridou, Amalia Baroutidou, Antonios Ziakas, Apostolos Tzikas, George Giannakoulas